Logo image of AXR

AMREP CORP (AXR) Stock Fundamental Analysis

NYSE:AXR - New York Stock Exchange, Inc. - US0321591051 - Common Stock - Currency: USD

22.14  +0.14 (+0.64%)

Fundamental Rating

7

Overall AXR gets a fundamental rating of 7 out of 10. We evaluated AXR against 64 industry peers in the Real Estate Management & Development industry. AXR gets an excellent profitability rating and is at the same time showing great financial health properties. A decent growth rate in combination with a cheap valuation! Better keep an eye on AXR. These ratings would make AXR suitable for value and quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

AXR had positive earnings in the past year.
AXR had a positive operating cash flow in the past year.
Each year in the past 5 years AXR has been profitable.
In the past 5 years AXR always reported a positive cash flow from operatings.
AXR Yearly Net Income VS EBIT VS OCF VS FCFAXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 9.51%, AXR belongs to the top of the industry, outperforming 96.88% of the companies in the same industry.
AXR has a Return On Equity of 9.78%. This is amongst the best in the industry. AXR outperforms 89.06% of its industry peers.
The Return On Invested Capital of AXR (8.01%) is better than 95.31% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AXR is above the industry average of 5.67%.
The 3 year average ROIC (7.98%) for AXR is below the current ROIC(8.01%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.51%
ROE 9.78%
ROIC 8.01%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
AXR Yearly ROA, ROE, ROICAXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

AXR has a Profit Margin of 25.59%. This is amongst the best in the industry. AXR outperforms 92.19% of its industry peers.
AXR's Profit Margin has declined in the last couple of years.
AXR has a Operating Margin of 24.36%. This is amongst the best in the industry. AXR outperforms 87.50% of its industry peers.
In the last couple of years the Operating Margin of AXR has declined.
With a decent Gross Margin value of 39.01%, AXR is doing good in the industry, outperforming 67.19% of the companies in the same industry.
In the last couple of years the Gross Margin of AXR has grown nicely.
Industry RankSector Rank
OM 24.36%
PM (TTM) 25.59%
GM 39.01%
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
AXR Yearly Profit, Operating, Gross MarginsAXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

9

2. Health

2.1 Basic Checks

AXR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AXR has been increased compared to 1 year ago.
AXR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, AXR has an improved debt to assets ratio.
AXR Yearly Shares OutstandingAXR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
AXR Yearly Total Debt VS Total AssetsAXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 20.97 indicates that AXR is not in any danger for bankruptcy at the moment.
AXR has a better Altman-Z score (20.97) than 96.88% of its industry peers.
AXR has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
The Debt to FCF ratio of AXR (0.00) is better than 92.19% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that AXR is not too dependend on debt financing.
AXR has a better Debt to Equity ratio (0.00) than 85.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 20.97
ROIC/WACC0.9
WACC8.87%
AXR Yearly LT Debt VS Equity VS FCFAXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.3 Liquidity

AXR has a Current Ratio of 28.03. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
AXR's Current ratio of 28.03 is amongst the best of the industry. AXR outperforms 98.44% of its industry peers.
AXR has a Quick Ratio of 10.42. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 10.42, AXR belongs to the best of the industry, outperforming 95.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 28.03
Quick Ratio 10.42
AXR Yearly Current Assets VS Current LiabilitesAXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

AXR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.86%, which is quite impressive.
The Earnings Per Share has been growing slightly by 2.33% on average over the past years.
Looking at the last year, AXR shows a decrease in Revenue. The Revenue has decreased by -3.26% in the last year.
AXR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.46% yearly.
EPS 1Y (TTM)89.86%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%-5.47%
Revenue 1Y (TTM)-3.26%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%-42.79%

3.2 Future

Based on estimates for the next years, AXR will show a small growth in Earnings Per Share. The EPS will grow by 2.71% on average per year.
Based on estimates for the next years, AXR will show a quite strong growth in Revenue. The Revenue will grow by 11.91% on average per year.
EPS Next Y-27.08%
EPS Next 2Y-9.75%
EPS Next 3Y-2.85%
EPS Next 5Y2.71%
Revenue Next Year124160%
Revenue Next 2Y3566.04%
Revenue Next 3Y13.25%
Revenue Next 5Y11.91%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AXR Yearly Revenue VS EstimatesAXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B
AXR Yearly EPS VS EstimatesAXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 2029 0.5 1 1.5 2 2.5

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.34, the valuation of AXR can be described as very reasonable.
Based on the Price/Earnings ratio, AXR is valued cheaper than 92.19% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.48, AXR is valued rather cheaply.
AXR is valuated correctly with a Price/Forward Earnings ratio of 12.82.
92.19% of the companies in the same industry are more expensive than AXR, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of AXR to the average of the S&P500 Index (34.04), we can say AXR is valued rather cheaply.
Industry RankSector Rank
PE 9.34
Fwd PE 12.82
AXR Price Earnings VS Forward Price EarningsAXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

98.44% of the companies in the same industry are more expensive than AXR, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AXR indicates a rather cheap valuation: AXR is cheaper than 90.63% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.17
EV/EBITDA 6.3
AXR Per share dataAXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

AXR has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as AXR's earnings are expected to decrease with -2.85% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.75%
EPS Next 3Y-2.85%

More info and screens

0

5. Dividend

5.1 Amount

AXR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMREP CORP

NYSE:AXR (8/8/2025, 7:00:00 PM)

22.14

+0.14 (+0.64%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-29 2025-07-29
Earnings (Next)09-11 2025-09-11
Inst Owners43.85%
Inst Owner Change0.19%
Ins Owners44.9%
Ins Owner Change0.84%
Market Cap117.56M
Analysts80
Price Target27.54 (24.39%)
Short Float %1.28%
Short Ratio2.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.34
Fwd PE 12.82
P/S 2.37
P/FCF 12.17
P/OCF 11.48
P/B 0.9
P/tB 0.9
EV/EBITDA 6.3
EPS(TTM)2.37
EY10.7%
EPS(NY)1.73
Fwd EY7.8%
FCF(TTM)1.82
FCFY8.22%
OCF(TTM)1.93
OCFY8.71%
SpS9.36
BVpS24.47
TBVpS24.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.51%
ROE 9.78%
ROCE 9.31%
ROIC 8.01%
ROICexc 11.51%
ROICexgc 11.54%
OM 24.36%
PM (TTM) 25.59%
GM 39.01%
FCFM 19.44%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
ROICexc(3y)10.52%
ROICexc(5y)13.87%
ROICexgc(3y)10.56%
ROICexgc(5y)13.9%
ROCE(3y)9.27%
ROCE(5y)12.5%
ROICexcg growth 3Y-24.11%
ROICexcg growth 5YN/A
ROICexc growth 3Y-24.15%
ROICexc growth 5YN/A
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 325.7%
Cap/Sales 1.17%
Interest Coverage 250
Cash Conversion 83.36%
Profit Quality 75.96%
Current Ratio 28.03
Quick Ratio 10.42
Altman-Z 20.97
F-Score6
WACC8.87%
ROIC/WACC0.9
Cap/Depr(3y)283.02%
Cap/Depr(5y)282.35%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.91%
Profit Quality(3y)86%
Profit Quality(5y)103.5%
High Growth Momentum
Growth
EPS 1Y (TTM)89.86%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%-5.47%
EPS Next Y-27.08%
EPS Next 2Y-9.75%
EPS Next 3Y-2.85%
EPS Next 5Y2.71%
Revenue 1Y (TTM)-3.26%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%-42.79%
Revenue Next Year124160%
Revenue Next 2Y3566.04%
Revenue Next 3Y13.25%
Revenue Next 5Y11.91%
EBIT growth 1Y59.26%
EBIT growth 3Y-17.16%
EBIT growth 5YN/A
EBIT Next Year-27.5%
EBIT Next 3Y-2.94%
EBIT Next 5Y6.19%
FCF growth 1Y-5.83%
FCF growth 3Y-12.03%
FCF growth 5Y66.27%
OCF growth 1Y-4.41%
OCF growth 3Y-12.86%
OCF growth 5Y67.79%